Feasibility and Usefulness of Intra-Cavitary Contrast-Enhanced Ultrasound in Percutaneous Nephrostomy

Cui, Xin‐Wu; Ignee, A.; Maros, T; Straub, Bernd F.; Wen, Jie; Dietrich, Christoph F.

doi:10.1016/j.ultrasmedbio.2016.04.015

Cited by 33 publications

(24 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The following clinical applications of EV-CEUS have been described in case studies: percutaneous nephrostomy [80], biliary tract imaging via percutaneous transhepatic cholangiography and drainage (PTCD) [81], abscess drainage [82], swallow CEUS for imaging Zenker's diverticulum, voiding vesicoureteral reflux sonography [83,84], salivary gland duct imaging [85], contrast-enhanced hysterosalpingo-sonography (CE-HyCoSy [86], biliary tract imaging via endoscopic retrograde cholangiography (ERCP) [87] and fistula imaging [88].…”

Section: Extravascular Intracavitarymentioning

confidence: 99%

Untitled

2018

Ultrasound Int Open

View full text Add to dashboard Cite

Section: Extravascular Intracavitarymentioning

confidence: 99%

Untitled

2018

Ultrasound Int Open

View full text Add to dashboard Cite

“…With IC-CEUS, it is possible to confirm the correct insertion of the needle or catheter and locate the obstruction. Complications such as catheter dislodgement and urine leakage may be easily diagnosed [156].…”

Section: Intracavitary Applicationsmentioning

confidence: 99%

Romanian National Guidelines on Contrast Enhanced Ultrasound in clinical practice

et al. 2017

View full text Add to dashboard Cite

Contrast-enhanced ultrasound (CEUS) allows a real-time assessment of the vascular pattern of different types of lesions, as it has no renal or liver toxicity, it lacks radiation exposure and it is also cheaper than other imaging methods, having a diagnostic capability that matches contrast-enhanced CT or MRI. In Romania CEUS is used more and more, especially by clinicians, and since some centres have extensive experience in this domain, we felt the need to disseminate our expertise in order to implement this method in as many centres as possible. These Guidelines present the clinical applications of CEUS in the liver, spleen, pancreas, kidney, testis, bowel, intra-cavitary and endoscopic ultrasound, as well as other applications.

show abstract

“…In addition, the use of contrast agent through the drainage catheter improves visualization of an abscess and complex fistula tract. Recently, contrast-enhanced US in the application of guiding PCN was first reported by Cui et al (30). In their study, 45 US-guided PCNs were performed in 35 patients with hydronephrosis resulting from urinary tract obstruction.…”

Section: Vascular and Interventional Radiology: Contrast-enhanced Us-mentioning

confidence: 99%

Contrast-enhanced US-assisted Percutaneous Nephrostomy: A Technique to Increase Success Rate for Patients with Nondilated Renal Collecting System

et al. 2017

View full text Add to dashboard Cite

Purpose To perform a single-center study of contrast material-enhanced ultrasonography (US)-assisted percutaneous nephrostomy (PCN) for patients with nondilated renal collecting system. Materials and Methods An international review board approved this retrospective study with waiver of informed consent for participation, and the study was approved by the Ethical Committee. From November 2011 to September 2015, 47 patients (mean age, 51.9 years ± 16.2 [standard deviation]; range, 18-80 years) with clinical necessity of urinary drainage, urinary diversion, or provision of access to the collecting system and with nondilated renal collecting system who underwent contrast-enhanced US-assisted PCN for 48 kidneys were included. US contrast agent was injected through the puncture needle and the drainage catheter to confirm successful PCN. The technical success rate and complications were evaluated. Relative frequencies with 95% confidence intervals (CIs) were calculated. Results The technical success rate was 100% (47 of 47, 95% CI: 93.8%, 100%) per patient and 100% (48 of 48, 95% CI: 94.0%, 100%) per kidney. For each kidney, the mean number of needle passes was 1.4 ± 0.5 (range, 1-3). The mean duration of the complete procedure was 18.9 minutes ± 4.8 (range, 8-30 minutes). The mean dose of contrast agent was 12.9 mL ± 3.2 (range, 8-25 mL). No major complications were observed. After a follow-up of 1-30 days (mean, 18.4 days ± 10.3), only four patients (four of 47, 8.5%, 95% CI: 2.37%, 20.4%) had minor complications, including one perirenal hematoma seen at US 9 days after the procedure and three patients with transient macroscopic hematuria that lasted 1-2 days. Conclusion Contrast-enhanced US-assisted PCN in patients with nondilated renal collecting system is valuable with high technical success rate. RSNA, 2017.

show abstract

Feasibility and Usefulness of Intra-Cavitary Contrast-Enhanced Ultrasound in Percutaneous Nephrostomy

Cited by 33 publications

References 24 publications

Untitled

Untitled

Romanian National Guidelines on Contrast Enhanced Ultrasound in clinical practice

Contrast-enhanced US-assisted Percutaneous Nephrostomy: A Technique to Increase Success Rate for Patients with Nondilated Renal Collecting System

Contact Info

Product

Resources

About